{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T06:43:57Z","timestamp":1790664237565,"version":"4.1.0"},"update-to":[{"DOI":"10.1002\/14651858.cd011983","type":"new_version","label":"New version","source":"publisher","updated":{"date-parts":[[2017,4,27]],"date-time":"2017-04-27T00:00:00Z","timestamp":1493251200000}}],"reference-count":60,"publisher":"Wiley","issue":"4","content-domain":{"domain":["wiley.com","cochranelibrary.com"],"crossmark-restriction":true},"short-container-title":[],"DOI":"10.1002\/14651858.cd011983.pub2","type":"journal-article","created":{"date-parts":[[2017,4,27]],"date-time":"2017-04-27T10:35:40Z","timestamp":1493289340000},"update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":21,"title":["Supervised dosing with a long-acting opioid medication in the management of opioid dependence"],"prefix":"10.1002","volume":"2017","author":[{"given":"Rosella","family":"Saulle","sequence":"first","affiliation":[{"name":"Lazio Regional Health Service; Department of Epidemiology; Via di S. Costanza Rome Italy 00198"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simona","family":"Vecchi","sequence":"additional","affiliation":[{"name":"Lazio Regional Health Service; Department of Epidemiology; Via di S. Costanza Rome Italy 00198"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Linda","family":"Gowing","sequence":"additional","affiliation":[{"name":"University of Adelaide; Discipline of Pharmacology; Frome Road Adelaide South Australia Australia 5005"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2017,4,27]]},"reference":[{"issue":"12","key":"10.1002\/14651858.CD011983.pub2-BIB0001|cit1","doi-asserted-by":"crossref","first-page":"1899","DOI":"10.1111\/j.1360-0443.2007.01979.x","article-title":"A randomized trial of effectiveness and cost-effectiveness of observed versus unobserved administration of buprenorphine-naloxone for heroin dependence","volume":"102","author":"Bell","year":"2007","journal-title":"Addiction (Abingdon, England)"},{"issue":"1","key":"10.1002\/14651858.CD011983.pub2-BIB0002|cit2","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1111\/add.13087","article-title":"Risk of mortality on and off methadone substitutiontreatment in primary care: a national cohort study","volume":"111","author":"Cousins","year":"2016","journal-title":"Addiction"},{"issue":"2","key":"10.1002\/14651858.CD011983.pub2-BIB0003|cit3","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1016\/j.pnpbp.2010.12.002","article-title":"Supervised daily consumption, contingent take-home incentive and non-contingent take-home in methadone maintenance","volume":"35","author":"Gerra","year":"2011","journal-title":"Progress in Neuro-Psychopharmacology and Biological Psychiatry"},{"issue":"4","key":"10.1002\/14651858.CD011983.pub2-BIB0004|cit4","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1111\/j.1465-3362.2011.00394.x","article-title":"A pilot randomised controlled trial of brief versus twice weekly versus standard supervised consumption in patients on opiate maintenance treatment","volume":"31","author":"Holland","year":"2012","journal-title":"Drug and Alcohol Review"},{"issue":"4","key":"10.1002\/14651858.CD011983.pub2-BIB0005|cit5","doi-asserted-by":"crossref","first-page":"596","DOI":"10.1111\/add.12439","article-title":"Treatment retention, drug use and social functioning outcomes in those receiving 3 months versus 1 month of supervised opioid maintenance treatment. Results from the Super C randomized controlled trial","volume":"109","author":"Holland","year":"2014","journal-title":"Addiction (Abingdon, England)"},{"issue":"5","key":"10.1002\/14651858.CD011983.pub2-BIB0006|cit6","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1111\/j.1360-0443.2011.03700.x","article-title":"Randomized trial of standard methadone treatment compared to initiating methadone without counseling: 12-month findings","volume":"107","author":"Schwartz","year":"2012","journal-title":"Addiction (Abingdon, England)"},{"issue":"2","key":"10.1002\/14651858.CD011983.pub2-BIB0007|cit7","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/S0376-8716(00)00141-1","article-title":"Thrice-weekly supervised dosing with the combination buprenorphine-naloxone tablet is preferred to daily supervised dosing by opioid-dependent humans","volume":"61","author":"Amass","year":"2001","journal-title":"Drug and Alcohol Dependence"},{"issue":"S1","key":"10.1002\/14651858.CD011983.pub2-BIB0008|cit8","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1080\/10550490490440780","article-title":"French field experience with buprenorphine","volume":"13","author":"Auriacombe","year":"2004","journal-title":"American Journal on Addiction"},{"key":"10.1002\/14651858.CD011983.pub2-BIB0009|cit9","doi-asserted-by":"crossref","first-page":"183-6","DOI":"10.1016\/j.drugalcdep.2008.02.012","article-title":"Optimising the benefits of unobserved dose administration for stable opioid maintenance patients: Follow-up of a randomised trial","volume":"96","author":"Bell","year":"2008","journal-title":"Drug and Alcohol Dependence"},{"issue":"11","key":"10.1002\/14651858.CD011983.pub2-BIB0010|cit10","doi-asserted-by":"crossref","first-page":"e112328","DOI":"10.1371\/journal.pone.0112328","article-title":"Methadone induction in primary care for opioid dependence: a pragmatic randomized trial (ANRS Methaville)","volume":"9","author":"Carrieri","year":"2014","journal-title":"PLoS One"},{"issue":"6","key":"10.1002\/14651858.CD011983.pub2-BIB0011|cit11","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1111\/dar.12062","article-title":"Treatment expectations and satisfaction of treatment-refractory opioid-dependent patients in RIOTT, the Randomised Injectable Opiate Treatment Trial, the UK's first supervised injectable maintenance clinics","volume":"32","author":"Groshkova","year":"2013","journal-title":"Drug and Alcohol Review"},{"issue":"3","key":"10.1002\/14651858.CD011983.pub2-BIB0012|cit12","doi-asserted-by":"publisher","first-page":"479","DOI":"10.1111\/add.12748","article-title":"Drug use, health and social outcomes of hard-to-treat heroin addicts receiving supervised injectable opiate treatment: secondary outcomes from the Randomized Injectable Opioid Treatment Trial (RIOTT)","volume":"110","author":"Metrebian","year":"2015","journal-title":"Addiction"},{"issue":"1","key":"10.1002\/14651858.CD011983.pub2-BIB0013|cit13","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1192\/bjp.bp.106.026112","article-title":"Heroin-assisted treatment for opioid dependence: randomised controlled trial","volume":"191","author":"Haasen","year":"2007","journal-title":"British Journal of Psychiatry : the journal of mental science"},{"issue":"7","key":"10.1002\/14651858.CD011983.pub2-BIB0014|cit14","doi-asserted-by":"crossref","first-page":"1055","DOI":"10.1046\/j.1360-0443.2000.95710557.x","article-title":"One-year follow-up of opiate injectors treated with oral methadone in a GP-centred programme","volume":"95","author":"Hutchinson","year":"2000","journal-title":"Addiction (Abingdon, England)"},{"issue":"9358","key":"10.1002\/14651858.CD011983.pub2-BIB0015|cit15","doi-asserted-by":"crossref","first-page":"662","DOI":"10.1016\/S0140-6736(03)12600-1","article-title":"1-year retention and social function after buprenorphine-assisted relapse prevention treatment for heroin dependence in Sweden: a randomised, placebo-controlled trial","volume":"361","author":"Kakko","year":"2003","journal-title":"Lancet"},{"issue":"5","key":"10.1002\/14651858.CD011983.pub2-BIB0016|cit16","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1046\/j.1360-0443.2002.00090.x","article-title":"A placebo-controlled study of high dose buprenorphine in opiate dependents waiting for medication-assisted rehabilitation in Oslo, Norway","volume":"97","author":"Krook","year":"2002","journal-title":"Addiction (Abingdon, England)"},{"key":"10.1002\/14651858.CD011983.pub2-BIB0017|cit17","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1186\/1477-7517-3-28","article-title":"Methodology for the Randomised Injecting Opioid Treatment Trial (RIOTT): evaluating injectable methadone and injectable heroin treatment versus optimised oral methadone treatment in the UK","volume":"3","author":"Lintzeris","year":"2006","journal-title":"Harm Reduction Journal"},{"issue":"1-2","key":"10.1002\/14651858.CD011983.pub2-BIB0018|cit18","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/j.drugalcdep.2012.12.009","article-title":"A randomised controlled trial of sublingual buprenorphine-naloxone film versus tablets in the management of opioid dependence","volume":"131","author":"Lintzeris","year":"2013","journal-title":"Drug and Alcohol Dependence"},{"issue":"9729","key":"10.1002\/14651858.CD011983.pub2-BIB0019|cit19","doi-asserted-by":"crossref","first-page":"1885","DOI":"10.1016\/S0140-6736(10)60349-2","article-title":"Supervised injectable heroin or injectable methadone versus optimised oral methadone as treatment for chronic heroin addicts in England after persistent failure in orthodox treatment (RIOTT): a randomised trial","volume":"375","author":"Strang","year":"2010","journal-title":"Lancet"},{"issue":"3","key":"10.1002\/14651858.CD011983.pub2-BIB0020|cit20","doi-asserted-by":"crossref","first-page":"159","DOI":"10.5055\/jom.2014.0204","article-title":"Implementation of a collaborative care management program with buprenorphine in primary care: a comparison between opioid-dependent patients and patients with chronic pain using opioids nonmedically","volume":"10","author":"Suzuki","year":"2014","journal-title":"Journal of Opioid Management"},{"issue":"7410","key":"10.1002\/14651858.CD011983.pub2-BIB0021|cit21","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1136\/bmj.327.7410.310","article-title":"Medical prescription of heroin to treatment resistant heroin addicts: two randomised controlled trials","volume":"327","author":"Brink","year":"2003","journal-title":"BMJ (Clinical research ed)"},{"issue":"10","key":"10.1002\/14651858.CD011983.pub2-BIB0022|cit22","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD004147.pub4","article-title":"Psychosocial combined with agonist maintenance treatments versus agonist maintenance treatments alone for treatment of opioid dependence","author":"Amato","year":"2011","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"2","key":"10.1002\/14651858.CD011983.pub2-BIB0023|cit23","first-page":"253-63","article-title":"Pharmacologicalmaintenance treatments ofopiate addiction","volume":"77","author":"Bell","year":"2014","journal-title":"British Journal of ClinicalPharmacology"},{"issue":"3","key":"10.1002\/14651858.CD011983.pub2-BIB0024|cit24","doi-asserted-by":"crossref","first-page":"293","DOI":"10.3109\/15360288.2010.503730","article-title":"Emergency department visits involving nonmedical use of selected prescription drugs in the United States, 2004-2008","volume":"24","author":"Cai","year":"2010","journal-title":"Journal of Pain & Palliative Care Pharmacotherapy"},{"key":"10.1002\/14651858.CD011983.pub2-BIB0025|cit25","first-page":"297-8","article-title":"Diversion and abuse of methadone prescribed for pain management","volume":"293","author":"Cicero","year":"2005","journal-title":"JAMA"},{"key":"10.1002\/14651858.CD011983.pub2-BIB0026|cit26","volume-title":"The Brief Pain Inventory. User Guide","author":"Cleeland","year":"2009"},{"issue":"5","key":"10.1002\/14651858.CD011983.pub2-BIB0027|cit27","doi-asserted-by":"crossref","first-page":"354","DOI":"10.3109\/14659891.2014.923532","article-title":"Opioid-dependence treatment in the era of recovery: insights from a UK survey of physicians, patients and out-of-treatment opioid users","volume":"20","author":"Dale-Perera","year":"2015","journal-title":"Journal of Substance Use"},{"key":"10.1002\/14651858.CD011983.pub2-BIB0028|cit28","unstructured":"Dolan K Mehrjerdi ZA Medication assisted treatment of opioid dependence: a review of the evidence Australian National Council on Drugs 2015"},{"key":"10.1002\/14651858.CD011983.pub2-BIB0029|cit29","unstructured":"Effective Practice and Organization of Care Cochrane Group. EPOC Resources for Cochrane Authors http:\/\/epoc.cochrane.org\/epoc-specific-resources-review-authors (accessed 22 February, 2016)"},{"key":"10.1002\/14651858.CD011983.pub2-BIB0030|cit30","first-page":"ES191-203","article-title":"Prescription opioid related misuse, harms, diversion and interventions in Canada: a review","volume":"5","author":"Fischer","year":"2012","journal-title":"Pain Physician"},{"key":"10.1002\/14651858.CD011983.pub2-BIB0031|cit31","doi-asserted-by":"crossref","first-page":"393-406","DOI":"10.1046\/j.1360-0443.2000.95339310.x","article-title":"Diversion of prescribed drugs by drug users in treatment: analysis of the UK market and new data from London","volume":"95","author":"Fountain","year":"2000","journal-title":"Addiction"},{"issue":"9","key":"10.1002\/14651858.CD011983.pub2-BIB0032|cit32","doi-asserted-by":"crossref","first-page":"743-51","DOI":"10.1097\/AJP.0b013e3181b01710","article-title":"Opioid use for chronic low back pain: A prospective, population-based study among injured workers in Washington state, 2002-2005","volume":"25","author":"Franklin","year":"2009","journal-title":"Clinical Journal of Pain"},{"key":"10.1002\/14651858.CD011983.pub2-BIB0033|cit33","unstructured":"Gowing L Ali R Dunlop A Farrell M Lintzeris N National Guidelines for Medication-Assisted Treatment of Opioid Dependence Print ISBN: 978-1-74241-944-2; Online ISBN: 978-1-74241-945-9 2014"},{"key":"10.1002\/14651858.CD011983.pub2-BIB0034|cit34","volume-title":"Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated March 2011]","author":"Higgins","year":"2011"},{"key":"10.1002\/14651858.CD011983.pub2-BIB0035|cit35","doi-asserted-by":"publisher","DOI":"10.17226\/13172","article-title":"Relieving Pain in America: A Blueprint for Transforming Prevention, Care, Education, and Research","volume-title":"The National Academies Press","author":"Institute of Medicine 2011","year":"2011"},{"issue":"11","key":"10.1002\/14651858.CD011983.pub2-BIB0036|cit36","doi-asserted-by":"publisher","first-page":"1230","DOI":"10.1016\/j.jpain.2010.07.002.","article-title":"The prevalence of chronic pain in United States adults: results of an Internet-based survey","volume":"11","author":"Johannes","year":"2010","journal-title":"Journal of Pain"},{"key":"10.1002\/14651858.CD011983.pub2-BIB0037|cit37","doi-asserted-by":"crossref","first-page":"513","DOI":"10.2147\/JPR.S47182","article-title":"Long-term opioid treatment of chronic nonmalignant pain: unproven efficacy and neglected safety?","volume":"6","author":"Kissin","year":"2013","journal-title":"Journal of Pain Research"},{"issue":"118(2-3)","key":"10.1002\/14651858.CD011983.pub2-BIB0038|cit38","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/j.drugalcdep.2011.04.002","article-title":"Post-marketing surveillance of buprenorphine-naloxone in Australia: diversion, injectionand adherence with supervised dosing","volume":"1","author":"Larance","year":"2011","journal-title":"Drug Alcohol Dependence"},{"issue":"3","key":"10.1002\/14651858.CD011983.pub2-BIB0039|cit39","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1111\/j.1465-3362.2010.00271.x","article-title":"Prescription opioid abuse, pain and addiction: Clinical issues and implications","volume":"30","author":"Ling","year":"2011","journal-title":"Drug and Alcohol Review"},{"issue":"3","key":"10.1002\/14651858.CD011983.pub2-BIB0040|cit40","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1111\/j.1465-3362.2011.00291.x","article-title":"The prescription drug epidemic in the United States: A perfect storm","volume":"30","author":"Maxwell","year":"2011","journal-title":"Drug and Alcohol Review"},{"issue":"13","key":"10.1002\/14651858.CD011983.pub2-BIB0041|cit41","doi-asserted-by":"crossref","first-page":"1689","DOI":"10.1001\/jama.284.13.1689","article-title":"Drug dependence, a chronic medical illness: implications for treatment, insurance, and outcomes evaluation","volume":"284","author":"McLellan","year":"2000","journal-title":"JAMA"},{"issue":"3","key":"10.1002\/14651858.CD011983.pub2-BIB0042|cit42","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1016\/0304-3959(75)90044-5","article-title":"The McGill Pain Questionnaire: major properties and scoring methods","volume":"1","author":"Melzack","year":"1975","journal-title":"Pain"},{"key":"10.1002\/14651858.CD011983.pub2-BIB0043|cit43","unstructured":"NICE Technology appraisal guidance-Methadone and buprenorphine for the management of opioid dependence 2007 https:\/\/www.nice.org.uk\/guidance\/ta114"},{"issue":"1","key":"10.1002\/14651858.CD011983.pub2-BIB0044|cit44","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1111\/dar.12079","article-title":"Regaining control: the patient experience of supervised compared to unsupervised consumption in opiate substitution treatment","volume":"33","author":"Notley","year":"2014","journal-title":"Drug and Alcohol Review"},{"key":"10.1002\/14651858.CD011983.pub2-BIB0045|cit45","unstructured":"Copenaghen: The Nordic Cochrane Centre Review Manager (RevMan) Version 5.3 2014"},{"issue":"4","key":"10.1002\/14651858.CD011983.pub2-BIB0046|cit46","doi-asserted-by":"crossref","first-page":"347-52","DOI":"10.1080\/09595230500263939","article-title":"The relationship between take-away methadone policies and methadone diversion","volume":"24","author":"Ritter","year":"2005","journal-title":"Drug and Alcohol Review"},{"issue":"5","key":"10.1002\/14651858.CD011983.pub2-BIB0047|cit47","doi-asserted-by":"crossref","first-page":"280","DOI":"10.5694\/mja10.11450","article-title":"Prescription of opioid analgesics and related harms in Australia","volume":"195","author":"Roxburgh","year":"2011","journal-title":"Medical Journal of Australia"},{"issue":"(50-51)","key":"10.1002\/14651858.CD011983.pub2-BIB0048|cit48","doi-asserted-by":"crossref","first-page":"1378","DOI":"10.15585\/mmwr.mm6450a3","article-title":"Increases in Drug and Opioid Overdose Deaths--United States, 2000-2014","volume":"64","author":"Rudd","year":"2016","journal-title":"MMWR. Morbidity and Mortality Weekly Report"},{"key":"10.1002\/14651858.CD011983.pub2-BIB0049|cit49","unstructured":"Substance Abuse and Mental Health Services Administration Center for Behavioral Health Statistics and Quality The DAWN Report: Highlights of the 2011 Drug Abuse Warning Network (DAWN) Findings on Drug-Related Emergency Department Visits. Accessed December 10, 2015 Available from: https:\/\/www.samhsa.gov\/data\/sites\/default\/files\/DAWN127\/DAWN127\/sr127-DAWN-highlights.htm"},{"key":"10.1002\/14651858.CD011983.pub2-BIB0050|cit50","unstructured":"SAMHSA 2015 Behavioral Health Trends in the United States: Results from the 2014 National Survey on Drug Use and Health HHS Publication No. SMA 15-4927, NSDUH Series H-50. Accessed January 2016"},{"issue":"4","key":"10.1002\/14651858.CD011983.pub2-BIB0051|cit51","doi-asserted-by":"publisher","first-page":"45","DOI":"10.3238\/arztebl.2013.0045.","article-title":"Increase in opiate prescription in Germany between 2000 and 2010: a study based on insurance data","volume":"110","author":"Schubert","year":"2013","journal-title":"Deutsches \u00c4rzteblatt International"},{"key":"10.1002\/14651858.CD011983.pub2-BIB0052|cit52","doi-asserted-by":"crossref","first-page":"995","DOI":"10.1046\/j.1360-0443.2003.00425.x","article-title":"The role of methadone in drug related deaths in the west of Scotland","volume":"98","author":"Seymour","year":"2003","journal-title":"Addiction"},{"key":"10.1002\/14651858.CD011983.pub2-BIB0053|cit53","first-page":"208-12","article-title":"Characterizing the emerging population of prescription opioid abusers","volume":"15","author":"Sigmon","year":"2006","journal-title":"American Journal on Addictions \/ American Academy of Psychiatrists in Alcoholism and Addictions"},{"key":"10.1002\/14651858.CD011983.pub2-BIB0054|cit54","unstructured":"United Nations Office on Drugs and Crime (UNODC) World Drug Report 2015 www.unodc.org\/documents\/wdr2015\/World_Drug_Report_2015.pdf"},{"key":"10.1002\/14651858.CD011983.pub2-BIB0055|cit55","unstructured":"United Nations Office on Drugs and Crime World Drug Report 2016 United Nations publication 2016"},{"key":"10.1002\/14651858.CD011983.pub2-BIB0056|cit56","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1186\/1477-7517-4-15","article-title":"Tampering by office-based methadone maintenance patients with methadone take home privileges: a pilot study","volume":"4","author":"Varenbut","year":"2007","journal-title":"Harm Reduction Journal"},{"key":"10.1002\/14651858.CD011983.pub2-BIB0057|cit57","unstructured":"World Health Organization Substitution maintenance therapy in the management of opioid dependence and HIV\/AIDS prevention, 2004 WHO\/UNODC\/UNAIDS position paper 2004"},{"key":"10.1002\/14651858.CD011983.pub2-BIB0058|cit58","unstructured":"WHO 2009 Guidelines for the Psychosocially Assisted Pharmacological Treatment of Opioid Dependence http:\/\/www.who.int\/hiv\/pub\/idu\/opioid\/en\/ 2009"},{"issue":"9","key":"10.1002\/14651858.CD011983.pub2-BIB0059|cit59","doi-asserted-by":"publisher","first-page":"1343","DOI":"10.1002\/j.1532-2149.2014.496.x.","article-title":"Changes in trends and pattern of strong opioid prescribing in primary care","volume":"18","author":"Zin","year":"2014","journal-title":"European Journal of Pain (London, England)"},{"issue":"12","key":"10.1002\/14651858.CD011983.pub2-BIB0060|cit60","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD011983","article-title":"Supervised dosing with a long acting opioid medication in the management of opioid dependence","author":"Saulle","year":"2015","journal-title":"Cochrane Database of Systematic Reviews"}],"container-title":["Cochrane Database of Systematic Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/full\/10.1002\/14651858.CD011983.pub2","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,16]],"date-time":"2023-10-16T08:47:27Z","timestamp":1697446047000},"score":1,"resource":{"primary":{"URL":"http:\/\/doi.wiley.com\/10.1002\/14651858.CD011983.pub2"}},"subtitle":[],"editor":[{"name":"Cochrane Drugs and Alcohol Group","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2017,4,27]]},"references-count":60,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2017,4]]}},"URL":"https:\/\/doi.org\/10.1002\/14651858.cd011983.pub2","relation":{},"ISSN":["1465-1858"],"issn-type":[{"value":"1465-1858","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,4,27]]}}}